Certificate under SEBI (Depositories and Participants) Regulations, 2018

7th July, 2026 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited., National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E), Mumbai - 400 001 Mumbai – 400 051 (BSE Scrip Code: 506943) (NSE Scrip Code: JBCHEPHARM) (Stock Symbol: JBCHEPHARM) Dear Sir/ Madam, Sub: Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 In compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, enclosed please find the Certificate received from Datamatics Business Solutions Limited, Registrar and Share Transfer Agents of the Company for the quarter ended June 30, 2026. You are requested to kindly take the above on record. Thanking you, Yours sincerely, For J.B. Chemicals & Pharmaceuticals Limited Sandeep Phadnis Vice President – Secretarial & Company Secretary DBSL/JB/QR/2026 July7,2026 TheComplianceOfficer/CompanySecretary JBChemicals&PharmaceuticalsLtd. NeelamCentre,Bwing4thfloor HindCycleRoad,Worli, Mumbai–400025 Sub: CertificateunderRegulation74(5)oftheSEBI(DepositoriesandParticipants) Regulations,2018forthequarterended30-06-2026 Ref: SecurityCode-506943 ISIN: INE572A01036 DearSir/Madam, We hereby certify that the securities received for dematerialization have been mutilated and cancelled afterdueverificationandthenameofthedepositoryhasbeensubstitutedinourrecordsastheregistered ownerwithin15daysofreceiptofcertificateofsecurity. Werequestyoutotakethisinformationonrecord. Thankingyou, Yoursfaithfully, ForDatamaticsBusinessSolutionsLtd